Meet the Peptide Track Speakers: Innovent Biologics, Gansu Pharma, and Federal Bio gather in Chengdu at 2026BPD!
2026,Peptide IndustryUndergoing a full-scale upgrade from the lab to production.
Capacity side accelerates first：SinobioConstruction of the Duoyi, Chengdu polypeptide API base with an annual capacity of 10 tons is scheduled to begin by the end of 10 in 2025.Ted MedicinePlan a new production line with an annual capacity of 3-5 tons;Federal BiologyZhuhai adds a new semaglutide API production line with an annual capacity of 182 kg.Clinical-side synchronization fulfillment: Gan & Lee PharmaceuticalsBofanaglutide's pivotal Phase III trial for weight loss met its primary endpoint; marketing application has been accepted.Innovent BiologicsH1 product revenue exceeded 82 billion yuan, up more than 55% year-over-year, with Mazdutide as the primary growth engine;PegBiotechCircular RNA-encoding GLP-1 receptor agonist CR059 achieves first-in-human dosing, supporting low-frequency administration. AI is redefining peptide discovery:Ped BiotechBuilt the world's largest toxic animal peptide library. Our self-developed EvoPulse platform reduced candidate discovery costs by 60%-70%, and our first pipeline was licensed for 9000 yuan.CSPC Pharmaceutical Group and AstraZenecaRegarding the partnership for the peptide AI discovery platform, the potential transaction value could reach up to $185 billion.
Once production capacity is built and molecules are released, the harder challenge is:How is the process scaled up? How are impurities controlled? How does the CMC strategy support global regulatory submissions?Against this backdrop,2026BPD Chengdu Biopharmaceutical Process Development Conferencewill be11 5-6InHyatt Place Chengdu Bio-CityGrandly hosted, bringing together2000+Professional Buyers,70+Headline speakers, headline planningInnovation and Scalable Production of Peptide DrugsForum session featuring technical presentations and case studies to build a focused, high-efficiency platform for deep industry insights and solving real-world challenges.Conference schedule and speaker bios now public!
Innovative R&D and Scalable Production of Peptide Drugs
Schedule updated through 10/15
